Title:
SUBSTITUTED HETEROARYL DERIVATIVE, AND COMPOSITION AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/166916
Kind Code:
A1
Abstract:
Provided are a substituted heteroaryl derivative, and a composition containing same and the use thereof, wherein the substituted heteroaryl derivative is a compound as represented by formula (I) or a tautomer, a stereoisomer, a prodrug, a crystal form, a pharmaceutically acceptable salt, a hydrate or a solvate thereof. The compound and the composition thereof can be used for the preparation of drugs for treating and/or preventing tumors mediated by wild-type and/or mutated EGFR and/or HER2 kinases.
Inventors:
WANG YIHAN (CN)
ZHAO JIUYANG (CN)
XING QINGFENG (CN)
ZHAO JIUYANG (CN)
XING QINGFENG (CN)
Application Number:
PCT/CN2022/075143
Publication Date:
August 11, 2022
Filing Date:
January 30, 2022
Export Citation:
Assignee:
SHENZHEN TARGETRX INC (CN)
International Classes:
A61K31/506; C07D401/02; A61P35/00; C07D401/14
Domestic Patent References:
| WO2010129802A1 | 2010-11-11 |
Foreign References:
| CN104860941A | 2015-08-26 | |||
| CN101861313A | 2010-10-13 |
Attorney, Agent or Firm:
LIU, SHEN & ASSOCIATES (CN)
Download PDF:
Previous Patent: COMPUTING POWER SERVICE METHOD AND DEVICE
Next Patent: TYK2 INHIBITOR COMPOUND CONTAINING BICYCLIC RING
Next Patent: TYK2 INHIBITOR COMPOUND CONTAINING BICYCLIC RING